Show simple item record

dc.contributor.authorSienel, RIen_US
dc.contributor.authorMamrak, Uen_US
dc.contributor.authorBiller, Jen_US
dc.contributor.authorRoth, Sen_US
dc.contributor.authorZellner, Aen_US
dc.contributor.authorParakaw, Ten_US
dc.contributor.authorKhambata, RSen_US
dc.contributor.authorLiesz, Aen_US
dc.contributor.authorHaffner, Cen_US
dc.contributor.authorAhluwalia, Aen_US
dc.contributor.authorSeker, BFen_US
dc.contributor.authorPlesnila, Nen_US
dc.date.accessioned2023-12-20T12:00:45Z
dc.date.available2023-12-07en_US
dc.date.issued2023-12-15en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/93163
dc.description.abstractIschemic stroke is a major global health issue and characterized by acute vascular dysfunction and subsequent neuroinflammation. However, the relationship between these processes remains elusive. In the current study, we investigated whether alleviating vascular dysfunction by restoring vascular nitric oxide (NO) reduces post-stroke inflammation. Mice were subjected to experimental stroke and received inhaled NO (iNO; 50 ppm) after reperfusion. iNO normalized vascular cyclic guanosine monophosphate (cGMP) levels, reduced the elevated expression of intercellular adhesion molecule-1 (ICAM-1), and returned leukocyte adhesion to baseline levels. Reduction of vascular pathology significantly reduced the inflammatory cytokines interleukin-1β (Il-1β), interleukin-6 (Il-6), and tumor necrosis factor-α (TNF-α), within the brain parenchyma. These findings suggest that vascular dysfunction is responsible for leukocyte adhesion and that these processes drive parenchymal inflammation. Reversing vascular dysfunction may therefore emerge as a novel approach to diminish neuroinflammation after ischemic stroke and possibly other ischemic disorders.en_US
dc.format.extent301 - ?en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofJ Neuroinflammationen_US
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
dc.subjectMiceen_US
dc.subjectAnimalsen_US
dc.subjectIschemic Strokeen_US
dc.subjectNitric Oxideen_US
dc.subjectNeuroinflammatory Diseasesen_US
dc.subjectStrokeen_US
dc.subjectTumor Necrosis Factor-alphaen_US
dc.subjectInflammationen_US
dc.subjectIntercellular Adhesion Molecule-1en_US
dc.titleInhaled nitric oxide suppresses neuroinflammation in experimental ischemic stroke.en_US
dc.typeArticle
dc.rights.holderCopyright © The Author(s) 2023
dc.identifier.doi10.1186/s12974-023-02988-3en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/38102677en_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume20en_US
dcterms.dateAccepted2023-12-07en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record